So if Lilly’s CEO John Lechleiter says Indiana needs to establish a world class research institute for life sciences, should resources in the state make it happen?
I’m still thinking about this, to be honest. Should Indiana play in the life science research space? Does the state have the right resources to make this successful?
You can read more of his comments at MedCity News.
Seems like a knee jerk reaction to me. But I’m just a medical device guy–not a pharma guy.